Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A

被引:108
作者
Luo, C
Luo, HB
Zheng, SX
Gui, CS
Yue, LD
Yu, CY
Sun, T
He, PL
Chen, J
Shen, JH
Luo, XM
Li, YX
Liu, H
Bai, DL
Shen, JK
Yang, YM
Li, FQ
Zuo, JP
Hilgenfeld, R
Pei, G
Chen, KX
Shen, X [1 ]
Jiang, HL
机构
[1] Chinese Acad Sci, Grad Sch Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med,Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Grad Sch Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Drug Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
[4] Nanjing Gen Hosp, Mol Biol Lab, Nanjing 210002, Peoples R China
[5] Med Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany
基金
中国国家自然科学基金;
关键词
severe acute respiratory syndrome; SARS coronavirus; nucleocapsid protein; cyclophilin A; surface plasmon resonance; site-directed mutagenesis; protein-protein interaction;
D O I
10.1016/j.bbrc.2004.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Severe acute respiratory syndrome coronavirus (SARS-CoV) is responsible for SARS infection. Nucleocapsid protein (NP) of SARS-CoV (SARS-NP) functions in enveloping the entire genomic RNA and interacts with viron structural proteins, thus playing important roles in the process of virus particle assembly and release. Protein-protein interaction analysis using bioinformatics tools indicated that SARS_NP may bind to human cyclophilin A (hCypA), and surface plasmon resonance (SPR) technology revealed this binding with the equilibrium dissociation constant ranging from 6 to 160nM. The probable binding sites of these two proteins were detected by modeling the three-dimensional structure of the SARS-NP-hCypA complex, from which the important interaction residue pairs between the proteins were deduced. Mutagenesis experiments were carried out for validating the binding model, whose correctness was assessed by the observed effects on the binding affinities between the proteins. The reliability of the binding sites derived by the molecular modeling was confirmed by the fact that the computationally predicted values of the relative free energies of the binding for SARS_NP (or hCypA) mutants to the wild-type hCypA (or SARS-NP) are in good agreement with the data determined by SPR. Such presently observed SARS_NP-hCypA interaction model might provide a new hint for facilitating the understanding of another possible SARS-CoV infection pathway against human cell. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:557 / 565
页数:9
相关论文
共 47 条
[1]   Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs [J].
Anand, K ;
Ziebuhr, J ;
Wadhwani, P ;
Mesters, JR ;
Hilgenfeld, R .
SCIENCE, 2003, 300 (5626) :1763-1767
[2]   Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro [J].
Bacha, U ;
Barrila, J ;
Velazquez-Campoy, A ;
Leavitt, SA ;
Freire, E .
BIOCHEMISTRY, 2004, 43 (17) :4906-4912
[3]   Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells [J].
Braaten, D ;
Luban, J .
EMBO JOURNAL, 2001, 20 (06) :1300-1309
[4]   C-H•••π-interactions in proteins [J].
Brandl, M ;
Weiss, MS ;
Jabs, A ;
Sühnel, J ;
Hilgenfeld, R .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :357-377
[5]   Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells [J].
Briggs, CJ ;
Tozser, J ;
Oroszlan, S .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2963-2967
[6]  
CASE DA, 2002, AMBER VERSION 7
[7]   Multiple sequence alignment with the Clustal series of programs [J].
Chenna, R ;
Sugawara, H ;
Koike, T ;
Lopez, R ;
Gibson, TJ ;
Higgins, DG ;
Thompson, JD .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3497-3500
[8]   Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus [J].
Cinatl, J ;
Morgenstern, B ;
Bauer, G ;
Chandra, P ;
Rabenau, H ;
Doerr, HW .
LANCET, 2003, 361 (9374) :2045-2046
[9]   Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J].
Drosten, C ;
Günther, S ;
Preiser, W ;
van der Werf, S ;
Brodt, HR ;
Becker, S ;
Rabenau, H ;
Panning, M ;
Kolesnikova, L ;
Fouchier, RAM ;
Berger, A ;
Burguière, AM ;
Cinatl, J ;
Eickmann, M ;
Escriou, N ;
Grywna, K ;
Kramme, S ;
Manuguerra, JC ;
Müller, S ;
Rickerts, V ;
Stürmer, M ;
Vieth, S ;
Klenk, HD ;
Osterhaus, ADME ;
Schmitz, H ;
Doerr, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1967-1976
[10]  
ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P112